Tetsuaki Arai

Setagaya, 1568585, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies.

Phosphorylated TDP-43 in Alzheimer's disease and dementia with Lewy bodies.

Journal: Acta neuropathologica

Published: December 05, 2008

TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Journal: Biochemical and biophysical research communications

Published: October 02, 2006

Neuronal and glial inclusions in frontotemporal dementia with or without motor neuron disease are immunopositive for p62.

Neuronal and glial inclusions in frontotemporal dementia with or without motor neuron disease are immunopositive for p62.

Journal: Neuroscience letters

Published: May 03, 2003

Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.

Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.

Journal: Acta neuropathologica

Published: November 15, 2001

Phenotypic heterogeneity of FTDP-17: implications for the differences of pathological phenotype among sporadic tauopathies.

Phenotypic heterogeneity of FTDP-17: implications for the differences of pathological phenotype among sporadic tauopathies.

Journal: Neurobiology of aging

Published: February 13, 2001

Immunohistochemical localization of amyloid beta-protein with amino-terminal aspartate in the cerebral cortex of patients with Alzheimer's disease.

Immunohistochemical localization of amyloid beta-protein with amino-terminal aspartate in the cerebral cortex of patients with Alzheimer's disease.

Journal: Brain research

Published: March 30, 1999

Argyrophilic glial inclusions in the midbrain of patients with Parkinson's disease and diffuse Lewy body disease are immunopositive for NACP/alpha-synuclein.

Argyrophilic glial inclusions in the midbrain of patients with Parkinson's disease and diffuse Lewy body disease are immunopositive for NACP/alpha-synuclein.

Journal: Neuroscience letters

Published: February 20, 1999

A high incidence of apolipoprotein E epsilon4 allele in middle-aged non-demented subjects with cerebral amyloid beta protein deposits.

A high incidence of apolipoprotein E epsilon4 allele in middle-aged non-demented subjects with cerebral amyloid beta protein deposits.

Journal: Acta neuropathologica

Published: February 04, 1999

Showing 1-8 of 8

Last Updated: 09/26/2026